How much does psychedelic business advice cost?

It depends heavily on scope. A short feasibility or regulatory scoping engagement costs far less than an ongoing advisory retainer covering multiple jurisdictions. Psilonautica scopes a written plan, timeline, and fee structure before any work begins, so there are no open-ended costs unless that suits the client.

Do I need a psychedelic-specific consultant, or will a general startup advisor do?

General startup advice covers company formation, fundraising mechanics, and go-to-market strategy well. It typically doesn't cover psychedelic-specific regulatory frameworks, clinical trial design, or the reputational considerations unique to this sector. Most founders benefit from both: general startup counsel for standard company-building, and psychedelic-specific advice for the parts that are genuinely different.

What's the first thing I should do before launching a psychedelic business?

Get a clear picture of the regulatory pathway in your target jurisdiction before finalising your operating model. Structural decisions made without that picture are the most expensive mistakes to unwind later, because they often require rebuilding the entity, licensing approach, or clinical model from scratch.

Psychedelic Business Advice: A Practical Starting Guide

Sort the regulation before you design the product

In most industries you build the product and deal with compliance later. Here, that order will sink you. What actually decides your product, your entity structure and your route to market is whether psilocybin, MDMA, DMT or whatever else you're working with can legally reach a patient, participant or customer where you plan to operate. That question comes first, or nothing else you decide will hold.

First-time founders coming in from wellness or biotech get caught out by this more than anyone. They assume regulation here behaves the way it did in the industry they've just left. It doesn't. Scheduling, trial requirements and licensing differ enormously between countries, and a model that works in one is often flatly impossible in another.

Pick the jurisdiction before the business model

Plenty of early teams choose a jurisdiction for reasons that have nothing to do with regulations: where the founders happen to live, where it's cheapest to incorporate. The regulatory homework comes afterwards. That gets expensive. A clinic built around Australia's TGA authorised prescriber scheme doesn't transfer to the UK's Home Office licensing regime, and the reverse is just as true.

Shortlist two or three jurisdictions. Work out what each one actually permits for your specific model, not what the press coverage suggests it permits. Then commit. It's slower at the start and it saves you rebuilding the whole structure after launch.

Put compliance in front of investors, not behind them

Investors in this space know the regulation far better than they used to, and vague reassurance falls apart in diligence. If your data room can't say plainly why your model is legal where you operate today, and what happens to it if the rules shift, someone will find that hole. Far better it comes up in your pitch than halfway through diligence.

Treat your regulatory position as an asset in your fundraising materials rather than a footnote.

Common mistakes

Locking in an entity structure before checking it works under the target jurisdiction's licensing regime.
Assuming an approach that worked in one country will carry over to another with a few tweaks.
Treating compliance as a legal job for later rather than a design input from day one.
Neglecting relationships with the regulators.
Leaving compliance gaps until a funding round, when they were visible from the start.

When to bring in a consultant

Early. More usefully: before you finalise your entity structure, before you commit to a jurisdiction, and before investor materials go out. If you're already operating and have only just run into a compliance problem, a review of your model against current regulation is still worth doing. It's just a narrower piece of work than getting the structure right from the beginning.

That's the gap our startup consulting and regulatory consulting services exist to fill: advice built for this sector, rather than generic startup guidance bolted onto psychedelics.

Questions founders ask us most

A psychedelic business consultant advises founders and operators on the parts of the business that are specific to this sector: regulatory pathway, jurisdiction selection, clinical or research partnerships, investor materials, and operating model design. It's a narrower, more specialised remit than general startup consulting, because the regulatory and reputational stakes are higher and more sector-specific.